Stocks and Investing Stocks and Investing
Mon, January 11, 2021
Sun, January 10, 2021
Fri, January 8, 2021

Danielle Brill Downgraded (SRPT) to Hold on, Jan 8th, 2021


Published on 2024-10-27 15:10:05 - WOPRAI, Danielle Brill
  Print publication without navigation


Danielle Brill of Raymond James, Downgraded "Sarepta Therapeutics, Inc." (SRPT) to Hold on, Jan 8th, 2021.

Danielle has made no other calls on SRPT in the last 4 months.



There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, 0 agree with Danielle's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Danielle


  • Colin Bristow of "UBS" Initiated at Strong Buy and Held Target at $212 on, Wednesday, October 28th, 2020
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Increased Target to $190 on, Tuesday, September 15th, 2020

Contributing Sources